Literature DB >> 7068625

A polypeptide which reverses cap analogue inhibition of cell-free protein synthesis. Purification and binding to capped oligonucleotides.

G M Hellmann, L Y Chu, R E Rhoads.   

Abstract

An assay was developed to detect the component which recognizes the methylated 5'-terminus of messenger RNA (cap) during initiation of translation. Globin mRNA translation in a reticulocyte cell-free system was partially inhibited with cap analogues, and protein fractions were added to the system in an attempt to reverse inhibition. Such an activity was detected in the 500 mM KCl extract of rabbit reticulocyte ribosomes. The activity (cap analogue inhibition reversal) was purified 800-fold by precipitation with ammonium sulfate saturation, batchwise chromatography on DEAE-cellulose, centrifugation on sucrose gradients containing 100 and 500 mM KCl, and column chromatography on DEAE-cellulose and phosphocellulose. At some stages multiple peaks of activity were detected. Electrophoretic analysis of the final preparation revealed a single polypeptide of 24,000 daltons, making it likely that it is the same as the cap-binding protein detected by Sonenberg et al. (Sonenberg, N., Morgan, M. A., Merrick, W. C., and Shatkin, A. J. (1978) Proc. Natl. Acad. Sci. U. S. A. 75, 4843-4847), using a cross-linking assay. Direct binding of purified fractions of cap analog inhibition reversal factor to capped oligonucleotides of the form m7Gppp(Np)6-8G[32P]Cp could be demonstrated by both gel filtration on Sephadex G-50 and nitrocellulose membrane filtration. Binding was stimulated by MgCl2 and nucleoside triphosphates. An approximate association constant between oligonucleotide and protein of 3 X 10(8) M-1 was obtained.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068625

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  A nuclear cap binding protein from HeLa cells.

Authors:  M Ohno; N Kataoka; Y Shimura
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

2.  Isolation and characterization of factors from wheat germ that exhibit eukaryotic initiation factor 4B activity and overcome 7-methylguanosine 5'-triphosphate inhibition of polypeptide synthesis.

Authors:  S Lax; W Fritz; K Browning; J Ravel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  Identification of the cap binding domain of human recombinant eukaryotic protein synthesis initiation factor 4E using a photoaffinity analogue.

Authors:  D E Friedland; M T Shoemaker; Y Xie; Y Wang; C H Hagedorn; D J Goss
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

4.  Separation of protein synthesis initiation factor eIF4A from a p220-associated cap binding complex activity.

Authors:  D Etchison; S Milburn
Journal:  Mol Cell Biochem       Date:  1987-07       Impact factor: 3.396

5.  Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F.

Authors:  A De Benedetti; S Joshi-Barve; C Rinker-Schaeffer; R E Rhoads
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

Review 6.  eIF4F: a retrospective.

Authors:  William C Merrick
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.